The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) to Fermenta Biotech’s manufacturing facility situated at Dahej, Gujarat, India with no observations as to any significant objectionable conditions, and the inspection has been successfully ‘closed’ by the USFDA.
Fermenta Biotech (formerly known as DIL) is engaged in the business of research support services through their subsidiary Research Support International (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta Biotech (FBL).
